跳至主要内容
临床试验/CTRI/2025/12/099387
CTRI/2025/12/099387招募中不适用

Antibiotic Susceptibility Testing guided Antibiotics Utilization Evaluation

Indus International Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月29日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1

研究概览

简要总结

Antibiotics are a cornerstone of modern clinical practice, playing a critical role in the management of infectious diseases across outpatient, inpatient, and intensive-care settings. Unfortunately, due to their widespread misuse and overuse drive the global surge in antimicrobial resistance (AMR). AMR limits therapeutic options, increases morbidity and mortality, and leads to greater financial strain on healthcare systems.

Antibiotic susceptibility testing (AST) serves as a approach to optimize antibiotic decision-making by identifying pathogens and quantifying their susceptibility to various antibiotics, AST bridges the gap between empiric therapy and targeted therapy. Empiric regimens, though essential in acute settings, frequently rely on broad-spectrum agents. These medications are valuable for rapid coverage but may contribute disproportionately to AMR.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Age 18 or more than 18 years Admitted with suspected or confirmed bacterial infection Received at least one antibiotic prescription and AST testing.

排除标准

  • Viral or fungal infections without bacterial co-infection Antibiotic prescribed as prophylactic Discharged against medical advice Outpatients, patients with incomplete medical records.

研究者

发起方
Indus International Hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Anmoljot Singh

Indus International Hospital

研究点 (1)

Loading locations...

相似试验